Publication | Closed Access
Development and Validation of a Novel Signature to Predict Overall Survival in “Driver Gene–negative” Lung Adenocarcinoma (LUAD): Results of a Multicenter Study
51
Citations
30
References
2018
Year
The CSDW signature is a reliable prognostic tool and may represent genes that are potential drug targets for "driver gene-negative" lung adenocarcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1